MX2009008704A - Metodos para corregir desequilibrio entre resorcion de huesos y formacion de huesos, equipos y composiciones para llevarlos a cabo. - Google Patents

Metodos para corregir desequilibrio entre resorcion de huesos y formacion de huesos, equipos y composiciones para llevarlos a cabo.

Info

Publication number
MX2009008704A
MX2009008704A MX2009008704A MX2009008704A MX2009008704A MX 2009008704 A MX2009008704 A MX 2009008704A MX 2009008704 A MX2009008704 A MX 2009008704A MX 2009008704 A MX2009008704 A MX 2009008704A MX 2009008704 A MX2009008704 A MX 2009008704A
Authority
MX
Mexico
Prior art keywords
kits
methods
bone
compositions therefor
correcting imbalance
Prior art date
Application number
MX2009008704A
Other languages
English (en)
Inventor
Alain Moreau
Genevieve Mailhot
Original Assignee
Chu Sainte Justine
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chu Sainte Justine filed Critical Chu Sainte Justine
Publication of MX2009008704A publication Critical patent/MX2009008704A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4535—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom, e.g. pizotifen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/662—Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
    • A61K31/663—Compounds having two or more phosphorus acid groups or esters thereof, e.g. clodronic acid, pamidronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/23—Calcitonins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/29—Parathyroid hormone, i.e. parathormone; Parathyroid hormone-related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Immunology (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Se describen compuestos, métodos, usos, composiciones, equipos y paquetes para el tratamiento de desequilibrio entre resorción de huesos y formación de huesos, con base en usos de 4-fenil-2-propionamidotetralina (4-P-PDOT) y análogos, derivados, prodrogas, precursores de los mismos y sus sales.
MX2009008704A 2007-02-15 2008-02-15 Metodos para corregir desequilibrio entre resorcion de huesos y formacion de huesos, equipos y composiciones para llevarlos a cabo. MX2009008704A (es)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US89010007P 2007-02-15 2007-02-15
US91226707P 2007-04-17 2007-04-17
US91519607P 2007-05-01 2007-05-01
US93802507P 2007-05-15 2007-05-15
PCT/CA2008/000312 WO2008098379A1 (en) 2007-02-15 2008-02-15 Methods of correcting imbalance between bone resorption and bone formation and kits and compositions therefor

Publications (1)

Publication Number Publication Date
MX2009008704A true MX2009008704A (es) 2009-10-19

Family

ID=39689600

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2009008704A MX2009008704A (es) 2007-02-15 2008-02-15 Metodos para corregir desequilibrio entre resorcion de huesos y formacion de huesos, equipos y composiciones para llevarlos a cabo.

Country Status (12)

Country Link
US (2) US8129432B2 (es)
EP (1) EP2120912B1 (es)
JP (1) JP5485704B2 (es)
KR (1) KR101394594B1 (es)
CN (1) CN101677978B (es)
AU (1) AU2008215081B2 (es)
CA (1) CA2677703C (es)
HK (1) HK1137361A1 (es)
IL (1) IL200189A (es)
MX (1) MX2009008704A (es)
WO (1) WO2008098379A1 (es)
ZA (1) ZA200905328B (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108264568B (zh) * 2016-12-30 2021-11-16 博晟生医股份有限公司 重组多肽、核酸分子及其组合物以及制造、使用其的方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5151466A (en) * 1987-01-16 1992-09-29 Phadke Shrikant V Single step bulk process for high impact polyester masterbatches, products thereof and blends with polyesters
US5151446A (en) * 1989-09-25 1992-09-29 Northwestern University Substituted 2-amidotetralins as melatonin agonists and antagonists
US5071875A (en) * 1989-09-25 1991-12-10 Northwestern University Substituted 2-amidotetralins as melatonin agonists and antagonists
SE9101642D0 (sv) 1991-05-30 1991-05-30 Kabi Pharmacia Ab Phospholipids
US5856124A (en) 1994-06-17 1999-01-05 The General Hospital Corporation DNA encoding high-affinity melatonin receptors
FR2771739B1 (fr) 1997-11-28 2001-04-20 Adir Nouveaux composes naphtaleniques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
US20050019841A1 (en) 1999-05-14 2005-01-27 Arbor Vita Corporation Modulation of signaling pathways
US20060134109A1 (en) 2002-09-09 2006-06-22 Nura Inc. G protein coupled receptors and uses thereof
US7365209B2 (en) 2003-02-11 2008-04-29 Pharmacopeia, Inc. Nitrogen heterocycle biaryls for osteoporosis and other diseases
WO2005078455A1 (en) 2004-02-18 2005-08-25 Bayer Healthcare Ag Diagnostics and therapeutics for diseases associated with human melatonin receptor type 1a (mtnr1a)
WO2005078444A1 (en) 2004-02-18 2005-08-25 Bayer Healthcare Ag Diagnostics and therapeutics for diseases associated with human melatonin receptor type 1b (mtnr1b)

Also Published As

Publication number Publication date
US20100029567A1 (en) 2010-02-04
KR101394594B1 (ko) 2014-05-14
US20120135930A1 (en) 2012-05-31
CA2677703A1 (en) 2008-08-21
EP2120912A4 (en) 2010-04-28
IL200189A0 (en) 2010-04-15
CN101677978B (zh) 2013-03-20
WO2008098379A1 (en) 2008-08-21
KR20090111335A (ko) 2009-10-26
EP2120912A1 (en) 2009-11-25
ZA200905328B (en) 2010-04-28
AU2008215081A1 (en) 2008-08-21
CA2677703C (en) 2014-08-05
US8129432B2 (en) 2012-03-06
HK1137361A1 (en) 2010-07-30
EP2120912B1 (en) 2013-04-03
IL200189A (en) 2015-01-29
JP5485704B2 (ja) 2014-05-07
US8222298B2 (en) 2012-07-17
CN101677978A (zh) 2010-03-24
AU2008215081B2 (en) 2013-07-18
JP2010518129A (ja) 2010-05-27

Similar Documents

Publication Publication Date Title
MY148253A (en) Azaadamantane derivatives and methods of use
NO20081554L (no) Isoindollmidforbindelser og sammensetninger omfattende samme, og anvendelse derav
MX2012003539A (es) Derivados de indol como moduladores de los canales de calcio activados por la liberacion de calcio (crac).
UA94833C2 (en) Substituted bicyclolactams
MX2009000884A (es) Derivados de piridizinona.
GEP201606555B (en) Compounds and compositions for modulating egfr activity
MX2009007075A (es) Metodos de uso para analogos de ciclopamina.
PH12013500365A1 (en) Anti-infective agents and uses thereof
MX344153B (es) Proceso para la preparación de sales de pirrolidinio.
MX2009009761A (es) Composiciones y estuches para tratamiento de la influenza.
TN2010000136A1 (en) Composition comprising sphingosine 1 phosphate (s1p) receptor modulators
MX2008013196A (es) 5-amido-2-carboxiamida-indoles.
MX2012015252A (es) Estimuladores de sgc.
MX2010002902A (es) Pirimidinas anti-infecciosas y usos de las mismas.
GB2453819A (en) Modulators of hypoxia inducible factor-1 and related uses
TW200726747A (en) Chemical compounds
TW200728302A (en) Chemical compounds VI
TW200730493A (en) Chemical compounds
GB2466912A (en) Compositions and methods for treating lysosomal disorders
MX2010008226A (es) Derivados de difluorobifenilamida para el tratamiento de hipertension ocular.
MX2011011776A (es) Nuevos profarmacos de triptolite.
MX2010004487A (es) Derivados lactamicos sustituidos y sus usos para glaucoma e hipertension ocular.
MX2009008028A (es) Agentes antiparasitarios.
BR112013003121A2 (pt) moduladores de trpv3
TN2009000536A1 (en) Novel herbicides

Legal Events

Date Code Title Description
FG Grant or registration